Recently added articles from Biotech Financial Reports:
PSIVIDA CORP. REPORTS RESULTS FOR 4TH QTR AND FISCAL YR.(Financial report)
Nov 01, 2009 ... pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) (FF: PV3), Watertown, Mass., a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back of the eye diseases, has announced financial results for its fourth quarter and ...
ST. JUDE MEDICAL ANNOUNCES PRELIMINARY 3RD QTR RESULTS.
Nov 01, 2009 ... St. Jude Medical, Inc. (NYSE:STJ), St. Paul, Minn. has announced preliminary results for the third quarter ended October 3, 2009. Preliminary Third Quarter Results The company expects to report net sales of approximately $1.159 billion in the third quarter of 2009, an ...
PATHWAY MEDICAL HAS 172% GROWTH OVER LAST 2 QUARTERS.(Pathway Medical Technologies Jetstream G2 NXT)
Nov 01, 2009 ... Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), has announced a 172 percent growth over the last two quarters with its Jetstream peripheral revascularization catheters at more than 150 centers of excellence in the United ...
OPEXA TRIGGERS MILESTONE PAYMENT UNDER STEM CELL PACT.
Nov 01, 2009 ... Opexa Therapeutics, Inc. (NASDAQ:OPXA),The Woodlands, Texas, a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), has announced that it has achieved its first technology transfer milestone in connection with the company's recently announced ...
ISORAY INC. ANNOUNCES FISCAL YEAR 2009 RESULTS.(Financial report)
Nov 01, 2009 ... IsoRay Inc. (AMEX:ISR), Richland, Wash., a medical isotope company focused on the treatment of lung cancer, head and neck tumors, prostate cancer and other malignant disease through use of its proprietary radioisotope technology, has announced its financial results for the quarter and year ...